Skip to content

Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke

Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke (ReFlow Study)

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01210729
Acronym
ReFlow
Enrollment
40
Registered
2010-09-28
Start date
2010-09-30
Completion date
2011-11-30
Last updated
2011-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Stroke

Keywords

stroke, mechanical recanalization, self-expanding stent, Solitaire

Brief summary

The objective of this study is to collect data on the use of the SOLITAIR FR device for treatment of acute ischemic stroke with large artery occlusion i.e. to investigate, whether the application of SOLITAIR is a safe and feasible method for interventional recanalization of large vessels with favorable patient outcome in acute stroke therapy.

Interventions

DEVICESolitaire FR, ev3

Placement of the stent in the occluded vessel segment, withdrawal in its unfolded state.

Sponsors

Universität des Saarlandes
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-85 years * Acute ischemic stroke with occlusion if ICA, MCA, VA or BA (TICI 0 or 1 flow) within the first 6 hours

Exclusion criteria

* Rapidly improving neurological signs * NHISS\>30 or coma * Female patients, who are pregnant or lactating * Use of warfarin anticoagulation with INR \> 1.5 * Platelet count \< 30,000 * Glucose \< 50 mg/dL * Life expectancy of less than 90 days * Computed tomography (CT) or Magnetic Resonance Imaging (MRI) evidence of hemorrhage on presentation * CT showing hypodensity on presentation

Design outcomes

Primary

MeasureTime frame
Overall frequency of favourable clinical outcome (modified Rankin Scale 0 to 2), and unfavourable clinical outcome or death (modified Rankin Scale 3 to 6)Day 90

Secondary

MeasureTime frame
Arterial recanalization of occluded target vessel measured by Thrombolysis in Cerebral Infarction (TICI)score of 2b or 3 following the use of the SOLITAIRE FR DeviceDay 0
Excellent functional clinical outcome (modified Rankin Scale 0 or 1)Day 90
All causes of mortalityDay 90
Proportion of patients with rapid neurological improvement (more than 4 points on the NIHSS) during the first 24 hours after treatment.Day 1
Symptomatic intracranial haemorrhages up to 24 hours after treatment defined as homogeneous areas of haemorrhage, with or without mass effect or intraventricular extension with neurological deteriorationDay 1
Number of SOLITAIRE device runs until recanalizationDay 0
Time between arterial puncture and TICI 2b or 3 recanalizationDay 0
Number of patients with and degree of stenosis in the treated artery 90 days after recanalization with SOLITAIREDay 90
Number of patients in which thrombus material was preservedDay 0
Histological examination of the thrombus material in correlation with TICI 2b or 3 recanalization and favorable clinical outcomeDay 1
Overall frequency of modified Rankin Scale 0 to 2 at 30 daysDay 30
Time between arterial puncture and Flow RestorationDay 0

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026